Related Experiment Video

Updated: Jul 5, 2026

Digital Home-Monitoring of Patients after Kidney Transplantation: The MACCS Platform
07:13

Digital Home-Monitoring of Patients after Kidney Transplantation: The MACCS Platform

Published on: April 12, 2021

Management of dyslipidemia in patients after solid organ transplantation

Lisa R Tannock1, L Raymond Reynolds

  • 1Veterans Affairs Medical Center, Division of Endocrinology and Molecular Medicine, University of Kentucky, Room 567 Wethington Building, 900 S. Limestone, Lexington, KY 40536-0200, USA. lisa.tannock@uky.edu

Postgraduate Medicine
|May 10, 2008
PubMed

Insights

Primary care physicians now manage transplant patients, who face high cardiovascular disease risks. Lipid-lowering therapy is safe and effective for managing post-transplant hyperlipidemia, despite limited large outcome trials.

Area of Science:

  • Cardiology
  • Nephrology
  • Transplant Medicine

Background:

  • Organ transplantation requires primary care physician involvement in patient management.
  • Cardiovascular disease is the leading cause of mortality in transplant recipients.
  • Transplant patients exhibit a higher prevalence of cardiovascular disease risk factors.

Purpose of the Study:

  • To review the evidence for lipid-lowering therapy in solid-organ transplant patients.
  • To discuss available treatment options for post-transplant hyperlipidemia.

Main Methods:

  • Review of existing literature on lipid-lowering therapy in transplant populations.
  • Analysis of smaller trials demonstrating safety and efficacy.
  • Comparison with evidence from the general population.

Main Results:

  • Post-transplant hyperlipidemia is highly prevalent due to underlying conditions and immunosuppressants.
  • While large outcome trials are lacking, smaller studies confirm the safety and efficacy of lipid-lowering agents.
  • Evidence supports lipid management in transplant patients, mirroring non-transplant populations.

Conclusions:

  • Lipid-lowering therapy is a crucial component of cardiovascular risk management in solid-organ transplant recipients.
  • Primary care physicians should be aware of and utilize available evidence-based treatment options.

More Related Videos

A Familial Hypercholesterolemia Human Liver Chimeric Mouse Model Using Induced Pluripotent Stem Cell-derived Hepatocytes10:56

A Familial Hypercholesterolemia Human Liver Chimeric Mouse Model Using Induced Pluripotent Stem Cell-derived Hepatocytes

Published on: September 15, 2018

Related Concept Videos

Lipid-Lowering Drugs: Statins and Miscellaneous Agents01:20

Lipid-Lowering Drugs: Statins and Miscellaneous Agents

Hyperlipidemia, a medical condition often referred to as high cholesterol, is characterized by abnormally elevated levels of lipids in the bloodstream. When present in excess, these lipids, specifically cholesterol and triglycerides, can lead to serious health complications, often involving cardiovascular diseases. Illnesses like atherosclerosis, heart attacks, and pancreatitis have all been linked to untreated hyperlipidemia. This means controlling and regulating cholesterol and triglyceride...
Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
Kidney Transplant III: Nursing Management01:16

Kidney Transplant III: Nursing Management

Postoperative Nursing Management for Kidney Transplant PatientsPostoperative nursing management care includes monitoring the surgical site, encouraging early movement, and promoting lung health through breathing exercises. Nurses also administer prescribed medications like H2-blockers, such as famotidine, or proton pump inhibitors, like omeprazole, to help prevent gastrointestinal ulcers and bleeding. Fungal infections in the mouth and bladder can result from immunosuppressive and antibiotic...
Lipids: Dietary Sources and Requirements01:18

Lipids: Dietary Sources and Requirements

Lipids are an essential component of a balanced human diet. Triglycerides, which make up the majority of dietary lipids, are found in both saturated fats—commonly present in meat, dairy products, and certain tropical plants like coconut, and hydrogenated oils such as margarine and baking shortenings (trans fats)—and unsaturated fats, which are abundant in seeds, nuts, olive oil, and most vegetable oils. The main sources of cholesterol include egg yolks, various meats and organ meats, shellfish,...
Angina IV: Management01:26

Angina IV: Management

IntroductionThe management of angina requires a comprehensive approach that includes pharmacological therapies, medical procedures, and lifestyle modifications.Pharmacological TherapiesAntiplatelet agents, such as aspirin, clopidogrel, prasugrel, and ticagrelor, play a pivotal role in preventing thrombus formation in patients with angina. These medications inhibit platelet aggregation and reduce the likelihood of myocardial infarction and other cardiovascular events.Anticoagulants, including...
Blood Studies for Cardiovascular System III: Serum Lipid Profile01:25

Blood Studies for Cardiovascular System III: Serum Lipid Profile

Understanding serum lipids is crucial for maintaining cardiovascular health and preventing heart disease and stroke.
Serum lipids are fats and fatty substances in the blood and are crucial for various bodily functions, including energy storage, cellular structure, and hormone production. Serum lipids consist of cholesterol, triglycerides, and phospholipids.
Cholesterol is a soft, fat-like substance found in all body cells. It is crucial for producing hormones, vitamin D, and substances that aid...